ADELPHANE-ESIDREX

This brand name is authorized in Estonia.

Active ingredients

The drug ADELPHANE-ESIDREX contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Reserpine UNII `8B1QWR724A` - RESERPINE
	Read more about Reserpine
`2`	Dihydralazine UNII `1C2B1W91NK` - DIHYDRALAZINE SULFATE
	Dihydralazine is a member of phthalazines.
	Read more about Dihydralazine
`3`	Hydrochlorothiazide UNII `0J48LPH2TH` - HYDROCHLOROTHIAZIDE
	Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted.
	Read more about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C02LA51	Reserpine and diuretics, combinations with other drugs	C Cardiovascular system → C02 Antihypertensives → C02L Antihypertensives and diuretics in combination → C02LA Rauwolfia alkaloids and diuretics in combination
Discover more medicines within C02LA51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1469415, 1629312

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.